Clinical trial NCT03649126: Nationwide Implementation of Standardized Structured Reporting
Official title: Nationwide Implementation of Standardized Structured Reporting to Support Optimal Treatment Decisions
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Standardized Structured Reporting
Keywords: standardized structured reporting
treatment decisions
multidisciplinary team
pathology
implementation tools
Lead sponsor: Radboud University Medical Center
Sponsor class: OTHER
Collaborators: name: Dutch Cancer Society
name: PALGA foundation
First posted: 2018-08-28
Enrollment: 50
Sex: ALL
Minimum age (years): 18
Maximum age (years): 68
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: OTHER
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Dutch pathologists, MDT-members and residents, using SSR of urological, gynecological or gastro-intestinal cancers.

Brief summary: The first objective is to explore factors that impede or facilitate implementation of SSR in pathology (and other disciplines) among the MDT members receiving SSRs. The second objective is to select, develop and evaluate (process and effect outcomes) implementation tools supporting optimal implementation of SSR in pathology. The third objective is to offer implementation tools to all pathology laboratories in the Netherlands and to share the SSR-kit for successful implementation with other medical disciplines

Detailed description: By implementing SSR in various disciplines, we contribute to improving communication, efficiency and quality of multidisciplinary team (MDT) meetings and facilitate optimal treatment decision making. Optimal discussion of each patient at MDT meetings can be achieved by a clear communication of all diagnostic results among MDT members. However, the adoption of innovations, such as SSR, is laborious, especially when the innovation requires changing daily habits. Offering implementation tools supports the adoption of innovations among medical professionals. Implementation tools are most effective when they are developed on the basis of factors that impede or facilitate the innovation. Besides the importance of investigating these factors for SSR among pathologists, we will also involve MDT members receiving pathology SSRs in our study. After all, because MDT members will greatly benefit from SSR, they could play a key role in stimulating the use of SSR among pathologists. Therefore, we will also explore which tools MDT members need to stimulate the diagnostic disciplines in using SSR. Subsequently, we will develop and evaluate implementation tools to support the use of SSR by pathologists. The kit for successful implementation of SSR will be offered to other medical disciplines like radiology, endoscopy, and surgery who face similar challenges with implementation of SSR. The SSR-kit consists of our multidisciplinary approach for the whole process of developing implementation tools for SSR, examples of tools for SSR, and other results of this project.

Eligibility criteria: Inclusion Criteria:

* Pathologists of urological, gynecological or gastro-intestinal cancers
* Other MDT-members of urological, gynecological or gastro-intestinal cancers (medical oncologists, radiologists, radiotherapists, urologists, gynecologists, intestinal surgeons, nuclear medicine physicians, nurse practitioners).
* Dutch
* Residents

Exclusion Criteria:

* Retirees

Primary outcomes:
measure: Barriers and facilitators in implementation of SSR in MDT - focus groups and self-developed questionnaire
timeFrame: 9 months
measure: Effectiveness of implementation tools - frequencies of use of SSR templates in pathology in the Netherlands
timeFrame: 6 months
Secondary outcomes:
measure: Determinants of barriers and facilitators in implementation of SSR - focus groups and a self-developed questionnaire
timeFrame: 1 month
measure: Experiences with implementation tools - questionnaire
timeFrame: 6 months
measure: Use of implementation tools - questionnaire
timeFrame: 6 months
Other outcomes:
Locations:
city: Nijmegen
country: Netherlands
facility: Radboud University Nijmegen Medical Center
state: Gelderland
Study officials:
References: